Richard joined the MHRA as a GMP Inspector in 2001 and is currently a Unit Manager with responsibility for the GMP and GPvP Inspection teams. Prior to joining the MHRA Richard worked in the pharmaceutical industry for over 17 years focusing mainly on the manufacture of bulk active pharmaceutical ingredients. He has experience of process development and technical support and has held managerial positions in both QA and production. Whilst at the MHRA, in addition to the inspection of a wide range of pharmaceutical manufacturers, Richard has been an Operations Manager with responsibility for teams of both GMP and GDP Inspectors and has most recently been part of the Agency team responsible for implementing the changes arising from the Falsified Medicines Directive.

Mark joined the MHRA in 2002 and is currently the Group Manager for the Inspectorate which comprises of over 80 Inspectors. Mark is a chemistry graduate with an MSc in pharmaceutical sciences. He previously worked in the pharmaceutical industry for over 10 years in a variety of roles including process technology, new product introduction and quality assurance and he is eligible to be named as a Qualified Person under Directive 2001/83/EC.

Kevin has been with the MHRA GMP Inspectorate since March 2016.  Before joining the MHRA he worked in the pharmaceutical industry for over 17 years. His roles included QC, validation and QA operations management.  He has worked on projects including transferring products between sites, commissioning of a new site, facility upgrades, introducing MES, data historian and site process control systems.  He has knowledge of a variety of dosage forms and is a Chartered Chemist.

More information coming soon.

David has been a GMDP inspector with the UK Medicines and Healthcare Products Regulatory Agency since 2004 with responsibility for leading inspections of pharmaceutical manufacturers and blood establishments in the UK and internationally. In his current role, David is the MHRA representative at the EMA Inspectors Working Group, and other EU and international groups to develop and revise GMP regulations and standards. David leads the agency team responsible for delivering data integrity inspection strategy and training, and is co-chair of the PIC/S data integrity working group. Prior to joining the MHRA, he was a Principal Pharmacist and production manager in the UK’s National Health Service, responsible for the manufacture of aseptically prepared radioactive diagnostic agents, chemotherapy and parenteral nutrition products.

Andy has been with the MHRA since March 2005 as a GMP Inspector and became a Senior GMP Inspector 2009.

Tracy has been with the MHRA GMP Inspectorate since 2011 and before joining the MHRA worked in the pharmaceutical industry for over 23 years. She worked across all dosage forms within Quality roles and is eligible to act as a Qualified Person under 2001/83. Tracy is the newly appointed lead for the Agency team responsible for delivering data integrity strategy and training.